Trinity Health — Ann Arbor, Michigan

Public research footprint of Trinity Health, compiled from the ClinicalTrials.gov public registry.

349

Registered studies

270

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma · Lung Non-Small Cell Carcinoma · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Trinity Health?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.